This VIAF Cluster has been deleted. It is no longer part of VIAF.
Siegrist, Claire-Anne
VIAF ID: 529155042718772401554 ( Unknown Name Type )
Permalink: http://viaf.org/viaf/529155042718772401554
Preferred Forms
Works
Title | Sources |
---|---|
Actualités vaccinologiques suisses : nouveaux vaccins glycoconjugués contre pneumocoques et méningocoques : nouveautés en médecine 2010 | |
Adénites cervicales unilatérales de l'enfant : approche diagnostique et thérapeutique | |
Antisense oligonucleotides specific for regulatory factor RFX-1 inhibit inducible but not constitutive expression of all major histocompatibility complex class II genes | |
Bases moléculaires de la reconnaissance des agents infectieux | |
Bone marrow transplantation in cartilage-hair hypoplasia : correction of the immunodeficiency but not of the chondrodysplasia | |
Brain microvascular endothelial cells and leukocytes derived from patients with multiple sclerosis exhibit increased adhesion capacity | |
Ce qu'il faut savoir d'une controverse regrettable | |
Cervical lymphadenitis caused by "mycobacterium genavense" in a healthy child | |
CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice | |
Les défis de la prévention des infections à virus respiratoire syncytial | |
Le développement de nouveaux vaccins à usage pédiatrique : progrès et défis | |
Disseminated osteomyelitis from "mycobacterium ulcerans" after a snakebite : brief report | |
Diversity and regulation of HLA class II genes : clinical implications | |
DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life | |
DNA vaccines : what can we expect ? | |
Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y | |
La grippe cet hiver : faut-il s'en préoccuper? | |
Hépatite B et sclérose en plaques : comment répondre aux inquiétudes du public ? | |
Hépatites virales chez l'enfant : diagnostic et prévention | |
Highly efficient peptide binding and T cell activation by MHC class II molecules of CIITA-transfected cells | |
HIV-1 in newborns | |
Immunity in early life : an introduction | |
Influence of maternal antibodies on vaccine responses : inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice | |
Influenza immunization : improving compliance of healthcare workers | |
Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load | |
Local variability in respiratory syncytial virus disease severity | |
Maternal immunity and infant responses to immunization : factors influencing infant responses | |
Medizinische Kontrolle von Kindern HIV-positiver Mütter | |
Mother-to-child transmission of human immunodeficiency virus type 1 : influence of parity and mode of delivery | |
Mother to child transmission of zidovudine-resistant HIV-1 | |
Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses : predominance of a Th2-biased pattern which persits after adult boosting | |
New challenges for global immunization | |
A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-γ | |
Pandemische Influenza A(H1N1)v- Impfung 2009/10 : was müssen wir wissen? | |
Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects | |
Pratique, problèmes et perspectives des vaccinations pédiatriques | |
Prevention of vertical HIV transmission : additive protective effect of elective Cesarean section and zidovudine prophylaxis | |
Procalcitonin is a marker of severity of renal lesions in pyelonephritis | |
Quand et comment faut-il prévenir ou traiter varicelle et zona chez un sujet sain ou immuno-déficient ? | |
Quel avenir pour les vaccins ? | |
Recommandations pour la prévention de la coqueluche : état janvier 1996 | |
Restriction of self-antigen presentation to cytolytic T lymphocytes by mouse peptide pumps | |
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer | |
Le SIDA et l'enfant | |
Specific tolerance to HIV-1 antigens in an infant with rapid progression to AIDS | |
The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes | |
Vaccin contre la rougeole obligatoire ? | |
Vaccination des sujets présentant un problème médical : précautions, contre-indications | |
Vaccination strategies for children with specific medical conditions : a paediatrician's viewpoint | |
Vaccines and vaccination | |
Vaccinologie : questions autour de la sécurité des vaccins adjuvantés contre la grippe A(H1N1) : nouveautés en médecine 2009 | |
Les vaccins contre l'hépatite B | |
Vaccins du futur | |
Who should receive chickenpox vaccination? |